Cargando…
A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles
BACKGROUND: In recent years, using hydroxyapatite nanoparticles (HANPs) for tumor therapy attracted increasing attention because HANPs were found to selectively suppress the growth of tumor cells but exhibit ignorable toxicity to normal cells. PURPOSE: This study aimed to investigate the capacities...
Autores principales: | Wu, Hongfeng, Liu, Shuo, Chen, Siyu, Hua, Yuchen, Li, Xiangfeng, Zeng, Qin, Zhou, Yong, Yang, Xiao, Zhu, Xiangdong, Tu, Chongqi, Zhang, Xingdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423115/ https://www.ncbi.nlm.nih.gov/pubmed/36046839 http://dx.doi.org/10.2147/IJN.S375950 |
Ejemplares similares
-
The in vitro and in vivo anti-melanoma effects of hydroxyapatite nanoparticles: influences of material factors
por: Wu, Hongfeng, et al.
Publicado: (2019) -
Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect
por: Zhang, Kun, et al.
Publicado: (2019) -
Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response
por: Zeng, Qin, et al.
Publicado: (2022) -
Electrochemical Deposition of Nanostructured Hydroxyapatite Coating on Titanium with Enhanced Early Stage Osteogenic Activity and Osseointegration
por: Lu, Minxun, et al.
Publicado: (2020) -
Effects of Nanotopography Regulation and Silicon Doping on Angiogenic and Osteogenic Activities of Hydroxyapatite Coating on Titanium Implant
por: Fu, Xi, et al.
Publicado: (2020)